Cell & Gene Therapy post-approval solutions to reduce scientific, regulatory and commercial risks, and accelerate development wherever you are in your product's development.

1. Supported the development of
BOTH
GENE
REPLACEMENT
THERAPIES
FDA approved
CAR-T therapies and helped
advance the first 2 FDA-approved
Real-World Evidence Studies
& Post-Marketing Commitments
Long-term follow-up studies
Disease and product registries
Global presence; deep therapeutic area expertise
~25 Project Managers
Database of 200,000 physicians worldwide
Contacts with regulatory and payers in
key markets
Access to policy, fee schedule payment data
and decision makers
Patient Safety & Pharmacovigilance
1,300+ safety professionals across the U.S., Europe and Asia Pacific
200+ person team of highly experienced safety writing professionals
120+ member team of medical reviewers–case review, aggregate
review and signal management
PV SMEs available locally in each region to provide guidance in
global and local regulations
CELL & GENE THERAPY
Post-Approval Solutions
With specialized expertise, coordinated capabilities and focused
investments across preclinical, clinical and post-approval phases, we’ll help
you to reduce the time and risk in your product’s development.
Processed
in the last
5 years
From intake
and case
processing
automation
Regulatory compliance
achieved in the last 4 years
~2.5M 55% >99.5%
CASES TIME
SAVINGS
Across all product & therapeutic areas

2. Precision Medicine Solutions Designed Around Your Needs
Visit us at www.covance.com/CGT
Covance is a business segment of LabCorp, a leading global life sciences company, which
provides contract research services to the drug, medical device and diagnostics, crop protection
and chemical industries. COVANCE is a registered trademark and the marketing name for
Covance Inc. and its subsidiaries around the world.
www.covance.com
© Copyright 2019 Covance Inc. SSCGT004-0220
Covering a variety of
disciplines
1,500+
CALL CENTER
STAFF
Precision Medicine Solutions Designed Around Your Needs
www.covance.com/CGT
Covance is a business segment of LabCorp, a leading global life sciences company, which
provides contract research services to the drug, medical device and diagnostics, crop protection
and chemical industries. COVANCE is a registered trademark and the marketing name for
Covance Inc. and its subsidiaries around the world.
© Copyright 2019 Covance Inc. SSCGT004-0220
CELL & GENE THERAPY
Post-Approval Solutions
Patient & Field Support
Field reimbursement
Clinical education
Payer and customer relations
120+ field team members and 300+
clinical educators (U.S.)
Non-commercial pharmacy
CMC Analytical Testing
Routine global lot and release and
stability testing
Out of Scope/Out of Trend data
trending and alerts
Long-term stability testing
Manufacturing comparability
Regulatory & Strategic Product
Development Consulting
Differentiation studies
Label/indication expansion
Combination strategy
Health economics
Per year for commercial
product (all product &
therapeutic areas)
900+
RELEASE EVENTS
Supporting regulatory
consulting, submissions
management and project
management
180STAFF